CMS proposes to hold drugmakers and PBMs accountable for cost of drugs covered by Medicaid

The Centers for Medicare and Medicaid Services has issued a proposed rule to drive down prescription drug costs in Medicaid by increasing price transparency. The rule would allow CMS to have more insight into what the most expensive drugs on the market actually cost to manufacture and distribute. CMS is not able to mandate that drug manufacturers lower the price of their

Related Keywords

Xavier Becerra ,Dan Tsai ,Anton Petrus Getty ,Children Health Insurance Program ,Drug Administration ,Centers For Medicare ,Medicaid Drug Rebate Program ,Medicaid Drug Price Verification ,Medicare Prescription Drug Inflation Rebate Program ,Medicaid Services ,Drug Misclassification Proposed Rule ,Drug Price Verification ,Health Insurance Program ,